300573 Stock Overview
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥212.50 |
| 52 Week High | CN¥239.50 |
| 52 Week Low | CN¥97.56 |
| Beta | 0.031 |
| 1 Month Change | -6.22% |
| 3 Month Change | 36.99% |
| 1 Year Change | 109.05% |
| 3 Year Change | 120.89% |
| 5 Year Change | 358.68% |
| Change since IPO | 3,904.04% |
Recent News & Updates
Shareholder Returns
| 300573 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.1% | -1.1% | -0.4% |
| 1Y | 109.1% | -15.9% | -16.2% |
Return vs Industry: 300573 exceeded the CN Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: 300573 exceeded the CN Market which returned -16.2% over the past year.
Price Volatility
| 300573 volatility | |
|---|---|
| 300573 Average Weekly Movement | 8.3% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 300573's share price has been volatile over the past 3 months.
Volatility Over Time: 300573's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 1,995 | E. Gao | www.sinqi.com |
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company offers corneal, anti-bacteria, artificial tears, anti-inflammation, anti-allergic, mydriactics, anti-fatigue, and dry eye treatment products.
Shenyang Xingqi Pharmaceutical Co.,Ltd. Fundamentals Summary
| 300573 fundamental statistics | |
|---|---|
| Market cap | CN¥26.48b |
| Earnings (TTM) | CN¥240.04m |
| Revenue (TTM) | CN¥1.47b |
110.3x
P/E Ratio18.0x
P/S RatioIs 300573 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300573 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.47b |
| Cost of Revenue | CN¥340.36m |
| Gross Profit | CN¥1.13b |
| Other Expenses | CN¥887.18m |
| Earnings | CN¥240.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 1.93 |
| Gross Margin | 76.81% |
| Net Profit Margin | 16.36% |
| Debt/Equity Ratio | 4.1% |
How did 300573 perform over the long term?
See historical performance and comparison